Valuation : Assure Holdings Corp.

Market Cap 144K 124K 117K 106K 199K 13.63M 201K 1.38M 536K 6.93M 539K 527K 23M P/E 2022
-0.13x
P/E 2023 -0.04x
Enterprise Value 14.83M 12.79M 12.03M 10.97M 20.6M 1.41B 20.75M 143M 55.36M 716M 55.66M 54.45M 2.37B EV / Sales 2022
1.68x
EV / Sales 2023 -4x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0.0001
4.2
1 year 0
Extreme 0.0001
4.2
3 years 0
Extreme 1.0E-6
17.64
5 years 0
Extreme 1.0E-6
2,934
10 years 0
Extreme 1.0E-6
6,299.99
Manager TitleAgeSince
Chief Executive Officer 67 15/05/2018
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 17/06/2021
Director TitleAgeSince
Chairman 67 15/05/2018
Director/Board Member 58 19/12/2018
Director/Board Member 76 19/09/2019
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/23 A Buy

Director

2,609 0.2369%
4/11/23 A Sell 2,500 0.2270%
4/11/23 A Buy

Director

500 0.0454%
Change 5-day change 1-year change 3-year change Capi.($)
-97.37%-.--%-98.96%-99.99% 1.84K
+3.93%+3.71%+33.42%+49.76% 120B
-0.21%-3.65%+2.38%+49.15% 89.73B
-0.75%-0.40%-1.20%+54.86% 29.6B
-1.70%-3.14%+30.05%+79.63% 26.52B
+0.90%-1.26%-2.53%-3.29% 21.71B
-0.03%-4.58%+44.22%+242.75% 21.41B
+1.42%-1.08%-8.77%+23.63% 14.81B
+0.23%-1.89%-9.71%-11.25% 12.14B
+0.07%-0.20%+27.86%+71.98% 11.22B
Average -9.78%-0.85%+1.68%+45.72% 34.73B
Weighted average by Cap. -0.24%-1.39%+17.12%+58.37%

Financials

2022 2023
Net sales 10.98M 9.47M 8.91M 8.12M 15.25M 1.04B 15.36M 106M 40.99M 530M 41.21M 40.31M 1.76B -4.1M -3.54M -3.33M -3.04M -5.7M -390M -5.74M -39.44M -15.32M -198M -15.4M -15.07M -657M
Net income -30.11M -25.97M -24.44M -22.28M -41.84M -2.86B -42.14M -289M -112M -1.45B -113M -111M -4.82B -26.08M -22.49M -21.16M -19.29M -36.24M -2.48B -36.49M -251M -97.39M -1.26B -97.91M -95.78M -4.18B
Net Debt 13.45M 11.6M 10.91M 9.95M 18.69M 1.28B 18.82M 129M 50.22M 649M 50.49M 49.39M 2.15B 14.68M 12.66M 11.91M 10.86M 20.4M 1.39B 20.55M 141M 54.83M 709M 55.12M 53.92M 2.35B
Logo Assure Holdings Corp.
Assure Holdings Corp. is a provider of Intraoperative neuromonitoring (IONM). The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, cardiovascular, orthopedic, ear, nose, and throat (ENT), and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. It offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.
Employees
95
  1. Stock Market
  2. Stocks
  3. IONM Stock